Atea Pharmaceuticals, Inc.AVIRNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-20.45%
↑ 67% above average
Average (26q)
-62.42%
Historical baseline
Range
High:514.71%
Low:-1800.00%
Volatility
-3708.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -20.45% |
| Q2 2025 | -10.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -8.11% |
| Q3 2024 | 22.92% |
| Q2 2024 | 36.00% |
| Q1 2024 | -59.57% |
| Q4 2023 | -17.50% |
| Q3 2023 | -17.65% |
| Q2 2023 | 20.93% |
| Q1 2023 | -4.88% |
| Q4 2022 | -323.12% |
| Q3 2022 | 74.50% |
| Q2 2022 | 24.00% |
| Q1 2022 | -135.46% |
| Q4 2021 | 514.71% |
| Q3 2021 | -1800.00% |
| Q2 2021 | -94.59% |
| Q1 2021 | 48.00% |
| Q4 2020 | 213.64% |
| Q3 2020 | -4.76% |
| Q2 2020 | -149.11% |
| Q1 2020 | 14.33% |
| Q4 2019 | -28.13% |
| Q3 2019 | 78.06% |
| Q2 2019 | -59.09% |
| Q1 2019 | 0.00% |